Gut microbiota dysbiosis further exacerbates CRS by producing uremic toxins (e.g., TMAO), which enhance inflammation and fibrosis via NF-κB and TGF-β1 pathways (31, 32). Here, TGFB1 is linked to congenital rubella syndrome.